Galle P et al. Ramucirumab for patients with advanced hepatocellular carcinoma and elevated alpha-fetoprotein following sorafenib: Outcomes by liver disease aetiology front wo randomised, placebo-controlled phase 3 studies (REACH-2 and REACH). (Abstract GS-09)
Langetermijneffectiviteit van Ad26.RSV.preF-RSV preF-eiwitvaccin
dec 2024 | Vaccinatie, Virale infecties